AlphaFold predicted structure
DLC1 · Q96QB1

Mean pLDDT
55.9/ 100
Low
1,528 residues
Confidence breakdown
- Very high(≥ 90)20%
- Confident(70–90)17%
- Low(50–70)6%
- Very low(< 50)57%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
DLC1 Rho GTPase activating protein
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Proteinuric renal disease
BIALLELIC, autosomal or pseudoautosomalAbnormality of the skeletal system
atrial fibrillation
cervical carcinoma
colon carcinoma
Varicose veins
tooth disorder
preeclampsia
ovarian dysfunction
secondary malignant neoplasm
Precordial pain
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Rho GTPase-activating protein 7
Functions as a GTPase-activating protein for the small GTPases RHOA, RHOB, RHOC and CDC42, terminating their downstream signaling. This induces morphological changes and detachment through cytoskeletal reorganization, playing a critical role in biological processes such as cell migration and proliferation. Also functions in vivo as an activator of the phospholipase PLCD1. Active DLC1 increases cell migration velocity but reduces directionality. Required for growth factor-induced epithelial cell migration; in resting cells, interacts with TNS3 while PTEN interacts with the p85 regulatory subunit of the PI3K kinase complex but growth factor stimulation induces phosphorylation of TNS3 and PTEN, causing them to change their binding preference so that PTEN interacts with DLC1 and TNS3 interacts with p85 (PubMed:26166433). The PTEN-DLC1 complex translocates to the posterior of migrating cells to activate RHOA while the TNS3-p85 complex translocates to the leading edge of migrating cells to promote RAC1 activation (PubMed:26166433)
Curated MONDO disease pages that list DLC1 among their top associated genes.
DLC1 · Q96QB1

Mean pLDDT
55.9/ 100
Low
1,528 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0